133 related articles for article (PubMed ID: 3633578)
1. Nephrotoxicity of cancer treatment.
Lydon J
Oncol Nurs Forum; 1986; 13(2):68-77. PubMed ID: 3633578
[No Abstract] [Full Text] [Related]
2. [Nephrotoxicity of antineoplastic drugs].
Suzuki T; Nosaka K
Ryoikibetsu Shokogun Shirizu; 1997; (16 Pt 1):542-6. PubMed ID: 9277811
[No Abstract] [Full Text] [Related]
3. Prevention of cisplatin nephrotoxicity: state of the art and recommendations from the European Society of Clinical Pharmacy Special Interest Group on Cancer Care.
Launay-Vacher V; Rey JB; Isnard-Bagnis C; Deray G; Daouphars M;
Cancer Chemother Pharmacol; 2008 May; 61(6):903-9. PubMed ID: 18317762
[TBL] [Abstract][Full Text] [Related]
4. Urinary tract toxic effects of cancer therapy.
Goldberg ID; Garnick MB; Bloomer WD
J Urol; 1984 Jul; 132(1):1-6. PubMed ID: 6233430
[No Abstract] [Full Text] [Related]
5. Hemolytic anemia associated with antineoplastic agents.
Doll DC; Weiss RB
Cancer Treat Rep; 1985; 69(7-8):777-82. PubMed ID: 3160460
[TBL] [Abstract][Full Text] [Related]
6. Amifostine protects against cisplatin-induced nephrotoxicity in a child with medulloblastoma.
Hayek M; Srinivasan A
Pediatr Hematol Oncol; 2003; 20(3):253-6. PubMed ID: 12637222
[No Abstract] [Full Text] [Related]
7. How to keep kidneys safe while shrinking tumors: the conundrum of cisplatin action.
Goligorsky MS
Am J Physiol Renal Physiol; 2007 Jul; 293(1):F50-1. PubMed ID: 17507601
[No Abstract] [Full Text] [Related]
8. Cisplatin nephrotoxicity affects magnesium and calcium metabolism.
Goren MP
Med Pediatr Oncol; 2003 Sep; 41(3):186-9. PubMed ID: 12868117
[TBL] [Abstract][Full Text] [Related]
9. Nephrotoxicity from chemotherapy: prevention and management.
Vogelzang NJ
Oncology (Williston Park); 1991 Oct; 5(10):97-102, 105; disc. 105, 109-11. PubMed ID: 1838278
[TBL] [Abstract][Full Text] [Related]
10. Modern methods for diagnosis and monitoring of nephrotoxicity during antitumor therapy with platinum derivatives.
Lyubimova NV; Topchieva SV; Averinova SG; Kashkadaeva AV; Gorbunova VA; Shiryaev SV; Kushlinskii NE
Bull Exp Biol Med; 2000 Sep; 130(9):886-91. PubMed ID: 11177273
[TBL] [Abstract][Full Text] [Related]
11. [Renal late effects in patients treated for cancer in childhood].
Sudour-Bonnange H; Vanrenterghem A; Nobili F; Guigonis V; Boudailliez B
Bull Cancer; 2015; 102(7-8):627-35. PubMed ID: 25935232
[TBL] [Abstract][Full Text] [Related]
12. Regulation of PUMA-alpha by p53 in cisplatin-induced renal cell apoptosis.
Jiang M; Wei Q; Wang J; Du Q; Yu J; Zhang L; Dong Z
Oncogene; 2006 Jul; 25(29):4056-66. PubMed ID: 16491117
[TBL] [Abstract][Full Text] [Related]
13. Summary and prospective statement concerning the genitourinary workshop.
Frei E
Cancer Clin Trials; 1981; 4 Suppl():25-9. PubMed ID: 6458418
[No Abstract] [Full Text] [Related]
14. Cisplatin: a review of toxicities and therapeutic applications.
Barabas K; Milner R; Lurie D; Adin C
Vet Comp Oncol; 2008 Mar; 6(1):1-18. PubMed ID: 19178659
[TBL] [Abstract][Full Text] [Related]
15. Role of oxidative and nitrosative stress in cisplatin-induced nephrotoxicity.
Chirino YI; Pedraza-Chaverri J
Exp Toxicol Pathol; 2009 May; 61(3):223-42. PubMed ID: 18986801
[TBL] [Abstract][Full Text] [Related]
16. Sodium-wasting nephropathy caused by cisplatin in esophageal cancer.
Abdelghani L; Modha K; Albaddawi E; Subramanian S
J Support Oncol; 2008; 6(7):305-6. PubMed ID: 18847072
[No Abstract] [Full Text] [Related]
17. Comparison of oral and intravenous hydration and diuretic, choice for protecting cisplatin induced nephrotoxicity.
Dana R; Kachhwaha VS
Indian J Cancer; 1996 Dec; 33(4):168-70. PubMed ID: 9254992
[TBL] [Abstract][Full Text] [Related]
18. Amifostine reduces the incidence of cumulative nephrotoxicity from cisplatin: laboratory and clinical aspects.
Capizzi RL
Semin Oncol; 1999 Apr; 26(2 Suppl 7):72-81. PubMed ID: 10348264
[TBL] [Abstract][Full Text] [Related]
19. Application of cisplatin as intraoperative hyperthermic peritoneal lavage (IHPL) in patients with locally advanced gastric cancer: analysis of pharmacokinetics and of nephrotoxicity.
Kern W; Braess J; Kotschofsky M; Samel S; Becker H; Hiddemann W; Schleyer E
Anticancer Res; 2002; 22(5):3099-102. PubMed ID: 12530050
[TBL] [Abstract][Full Text] [Related]
20. Agents ameliorating or augmenting the nephrotoxicity of cisplatin and other platinum compounds: a review of some recent research.
Ali BH; Al Moundhri MS
Food Chem Toxicol; 2006 Aug; 44(8):1173-83. PubMed ID: 16530908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
